Q&A: ‘Astounding’ success for gene therapy in otoferlin-related deafness
Key takeaways: The investigational gene therapy DB-OTO improved hearing to normal levels in two children with congenital deafness. Researchers plan to follow the participants for the next 5 years. A gene therapy for otoferlin-related deafness was able to …